Effects of Clustering Care on the Physiological Stability of Preterm Infants.

January 14, 2020 updated by: Abril Nicole Fernandez Oviedo, Université de Montréal

Effects of Clustering Care on the Physiological Stability of Preterm Infants in a Neonatal Intensive Care Unit.

This crossover design experimental study aims to compare the physiological stability of premature newborns during and after a cluster of care compared to a period when they receive standard non clustered care at the neonatal unit.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The cluster care will take place at the time of feeding of the premature infants. The intervention will start with a calm period of 20 minutes before the start of care (no manipulations will be allowed), the baby will then received the cluster care for 20 minutes and a quiet period of 30 minutes will follow after the cluster care.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montréal, Quebec, Canada, H3T1E2
        • Jewish General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 months to 7 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • between 26 to 31 6/7 weeks of gestation at birth
  • more than 72 hours of life,
  • receive a respiratory aid such as endotracheal tube, NIPPV (non invasive positive pressures ventilation), CPAP (continuous positive airway pressure) or nasal prongs with oxygen,
  • are fed intravenously (IV) or by central venous catheter (CVC),
  • one of the parents speaks and reads English or French,
  • one of the parents is at least 18 years old to sign the consent.

Exclusion Criteria:

  • severely ill (necrotizing enterocolitis, septicemia),
  • under respiratory assistance or on a high frequency mode,
  • having a congenital or cardiac abnormality,
  • requiring surgery,
  • sedatives or opioids,
  • diagnosed with grade II, III or IV intraventricular hemorrhage and / or hydrocephalus,
  • have a device for invasive blood pressure,
  • having an oxygen requirement of more than 30% to maintain oxygen saturation within the limits indicated by the NICU (neonatal intensive care unit).
  • one of the parents is at least 18 years old to sign the consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Clustering care for 20 minutes.
During 20 minutes, preterm infants will receive a cluster care with 2 minutes of hand containment.
No Intervention: Control
Standard care non clustered.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiological stability (heart rate, respiratory rate and oxygen saturation)
Time Frame: The physiological stability will be measured for 70 minutes.
The physiological stability will be measured with the SCRIP score. The Stability of the cardiorespiratory system in premature infants is a scale, in which a score of 0 means major physiological instability and a score of 6 means a physiological stability. For every single parameter there's three grades from severe instability (0 points) to minor instability (1 point) to perfect stability (2 points).
The physiological stability will be measured for 70 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Marilyn Aita, PhD, Université de Montréal

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2018

Primary Completion (Actual)

April 3, 2019

Study Completion (Actual)

May 30, 2019

Study Registration Dates

First Submitted

March 23, 2018

First Submitted That Met QC Criteria

April 5, 2018

First Posted (Actual)

April 6, 2018

Study Record Updates

Last Update Posted (Actual)

January 18, 2020

Last Update Submitted That Met QC Criteria

January 14, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Etude_maitrise_2018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The results of this project could be made public in a journal or scientific congress.

IPD Sharing Time Frame

The results of the study will be available when the study is finished.

IPD Sharing Access Criteria

The results will be published in a scientific journal.

IPD Sharing Supporting Information Type

  • Clinical Study Report (CSR)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Baby 26 to 32 Weeks

Clinical Trials on Clustering care

3
Subscribe